EyePoint Inc logo

EyePoint Inc

EYPT
Healthcare|Biotechnology|USA
$14.72
-0.12 (-0.81%)
Tangible Book
$2.76

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1.98, 38.85, 301.69, 630.64, 913.5 ], "ebit_estimate": [ -330.99, -321.84, -199.53, -159.62, 153.35 ], "ebitda_estimate": [ -357.34, -25.6, 30.28, null, null ], "net_income_estimate": [ -317.05, -313.34, -154.63, -148.04, 159.33 ], "per_share_eps_estimate": [ -3.51, -3.01, -1.53, -1.29, 1.25 ], "eps_nri_estimate": [ -3.55, -3.06, -1.43, 0.39, 2.49 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 2.99, 2.84, 9.23, null, null ], "pretax_income_estimate": [ -317.08, -313.34, -146.74, -135.79, 180.03 ], "operating_cash_flow_per_share_estimate": [ -2.25, -0.48, 2.92, null, null ], "roa_estimate": [ -81.4, -22.5, 17.7, null, null ], "roe_estimate": [ -125.98, -113.33, -2.32, null, null ], "gross_margin_estimate": [ 28.55, 86.5, 84.33, 84.5, 85 ], "operating_cash_flow_estimate": [ -193.5, -41.28, 251.12, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 11.8 ], "long_term_growth_rate_mean": 26.04, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 24.65, "future_eps_nri_estimate_growth": 26.04, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 30.9, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 64.74, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 0.42, 0.34, 0.33, 0.6, 0.6, 0.6, 0.6 ], "ebit_estimate": [ -68.86, -66.02, -71, -84.26, -92.89, -86.54, -88.39 ], "ebitda_estimate": [ 0.03, -10.1, -17.8, null, null, null, null ], "net_income_estimate": [ -80.7, -74.75, -77.06, -82.62, -91.53, -85.52, -87.64 ], "per_share_eps_estimate": [ -0.94, -0.8, -0.8, -0.88, -0.97, -0.9, -0.84 ], "eps_nri_estimate": [ -0.95, -0.82, -0.82, -0.88, -0.97, -0.9, -0.84 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -80.7, -74.75, -77.05, -82.62, -91.53, -85.52, -87.64 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -157.53, -180.95, -211.71, null, null, null, null ], "gross_margin_estimate": [ 93, 93, -97, 93, 93, 93, 93 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 26.04, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 24.65, "future_eps_nri_estimate_growth": 26.04, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 30.9, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 64.74, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-08 15:49:59
2026-07-01 13:33:39
2026-06-24 14:37:07